Haihe Biopharma is based in Shanghai, China. It has raised $318M in total funding. Latest round: Series B. Backed by Warburg Pincus, CMBI, Legend Capital.
Haihe Biopharma is based in Shanghai, China. Haihe Biopharma has raised $318M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in July 2020. The round record for Haihe Biopharma runs through 2020; nothing later has been disclosed. Investors on record include Warburg Pincus, CMBI, Legend Capital, CICC Capital, Chaos Investment, ALAN Asset Management and 6 others. 12 distinct backers are named across the disclosed rounds.
Haihe Biopharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Shanghai below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026